Neumora Therapeutics, Inc. (NMRA)

NASDAQ

$0.42

$-0.05

(-9.98%)

Regular Market

Neumora Therapeutics, Inc. (NMRA) Live Price Chart

Last updated: ⁦2026-10-21 17:37:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Neumora Therapeutics, Inc. (NMRA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.42, with a market capitalization of $88.31M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.32 to $3.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$88.31M
Open	$0.47
Day's High	$21.00
Day's Low	$0.32
Previous Close	$0.47
Volume	775.37K
Average Volume	1.41M
P/E Ratio	--
52-Week High	$3.65
52-Week Low	$0.32
Dividend Yield	--
Earnings Date	--

Neumora Therapeutics, Inc. (NMRA) Stock Price Today

Neumora Therapeutics, Inc. (NMRA) is currently trading at $0.42 as of 2026-10-21 17:35:00, down 9.89% ($0.05) from the previous close of $0.47

During today's regular trading session, NMRA has traded between $0.32 and $21.00, with a trading volume of 775.37K shares. The current price is near the lower end of today's range.

Neumora Therapeutics, Inc. (NMRA) 7-Day Stock Price Change

Over the past seven days, Neumora Therapeutics, Inc. (NMRA) moved from $0.44 to $0.42, representing a decline of 4.18% ($0.02).

The stock traded between $0.32 and $0.51 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 2.59 million shares, up versus the previous seven-day period, indicating higher trading activity.

NMRA 52-Week Price Position

Position in Range: 3.1%

52W Low$0.32

52W High$3.65

NMRA is currently trading at $0.42, placing it 3.1% of the way from its 52-week low of $0.32 to its 52-week high of $3.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Neumora Therapeutics, Inc. (NMRA)?

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	63
Exchange	NASDAQ
Company Website	https://www.neumoratx.com

How to Buy Neumora Therapeutics, Inc. (NMRA) Stock on MEXC

Eligible investors can buy real shares of Neumora Therapeutics, Inc. (NMRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NMRA and Place Your Order

Open the RealStocks trading page and search for NMRA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Neumora Therapeutics, Inc. (NMRA) stock price today?

Neumora Therapeutics, Inc. (NMRA) is currently trading at $ 0.42, down 9.89% ($0.05) from the previous close of $ 0.47. Intraday prices update in real time during regular trading hours.

2.Is NMRA stock going up or down today?

As of 2026-10-21 17:35:00, NMRA is trading at $ 0.42, down 9.89% ($0.05) from its previous close of $ 0.47. The stock has traded between $ 0.32 and $ 21.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is NMRA pre-market price?

As of 2026-10-21 17:35:00, NMRA is trading at $ 0.49 in pre-market trading, up 5.16% ($0.02) from the previous close of $ 0.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NMRA after-hours price?

As of 2026-10-21 17:35:00, NMRA is trading at $ 0.47 in after-hours trading, up 0.22% ($0.00) from the regular-session close of $ 0.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NMRA stock trading now?

NMRA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NMRA sit relative to its 52-week high and low?

Over the past 52 weeks, NMRA has traded between a low of $ 0.32 and a high of $ 3.65. At $ 0.42, the stock is positioned 3.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Neumora Therapeutics, Inc. in?

Neumora Therapeutics, Inc. (NMRA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Neumora Therapeutics, Inc.'s market capitalization and where is it listed?

Neumora Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 88.31M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NMRA valued in terms of P/E ratio and EPS?

NMRA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.13. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Neumora Therapeutics, Inc. pay a dividend?

Neumora Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.